Author: OurCrowd

[Biolojic in GlobeNewswire] Biolojic Design appoints Neal Curran as Chief Business Officer

REHOVOT, Israel and WASHINGTON, Nov. 21, 2024 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced the appointment of Neal Curran as Chief Business Officer. Mr. Curran joins Biolojic Design with extensive experience in business development in the biopharmaceutical industry and comes to the company as it expands its business and development activities in the U.S. Read...

Read More

[Arrow Global in Alternative Credit Investor] Arrow Global reports record origination as funds under management hit €10.5bn

Arrow Global has reported record origination volumes in the third quarter of this year, while funds under management (FUM) rose to €10.5bn (£8.7bn). The European asset manager, which focuses on private credit and real estate, said that it has deployed €1.25bn over the year to date, €719m of which occurred during the third quarter, with a strong pipeline heading into the fourth quarter of the year. Read...

Read More

[Alloy Therapeutics in BusinessWire] Alloy Therapeutics signs collaboration and license agreement with Takeda to develop cell therapy platform

TOKYO & BOSTON–(BUSINESS WIRE)–Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced today a strategic collaboration and license agreement with Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK “Takeda”) to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell platform (iCAR-T) and iPSC-derived CAR-NK platform (iCAR-NK). Alloy will focus on accelerating the development of key therapies to overcome solid and hematological malignancies. Read...

Read More

[ADvantage in Business Wire] Ladder Secures Over $100 Million in New Funding to Scale #1 Strength Training App

AUSTIN, Texas–(BUSINESS WIRE)–Ladder, the #1 iOS app for strength training, announced today it has raised $15 million in Series B funding led by Point72 Ventures and ADvantage VC, with participation from Steve Pagliuca’s PagsGroup and Series A lead investors Tapestry VC and LivWell Ventures. Ladder has also secured a $90 million growth investment from General Catalyst’s Customer Value strategy, to provide financing for customer acquisition costs. The combined financing will allow Ladder to reach a global audience. Read...

Read More